Reaction
Administration Site Indentation reporting signals
As of the last recalculation, Administration Site Indentation appears in 57 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ALIROCUMAB (PRR 221.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alirocumab | 12 | 221.0 | 221.1 |
| Copper | 10 | 102.5 | 102.5 |